From geometry to machines

The Architecture Bridge

On the left, an idea you can play with in the Atlas. On the right, the part of Generatica, Faciens Technologies’ computing architecture, that it drives, where you can watch it working, and how far the claim has been tested. Nothing here is stronger than its evidence line says.

Generatica’s machine is a simulation whose hardware prices come from an independent cost model; Quester GX-1 is a chip design, not yet silicon; the medical device concepts are research-stage and computational. Each line below says which kind of evidence it rests on.

The same geometry, in medicine

A delivery problem about directions

Tumour-treating fields, already in clinical use for some brain and lung cancers, act on cells while they divide, and their effect depends on how the field lines up with each cell’s axis of division. Standard delivery alternates between two perpendicular directions, left-right and front-back. Both lie in one plane, so cells dividing along the third axis are barely reached by either.

Covering a sphere of orientations from a few chosen directions is the question of caps on the sphere, and choosing a sequence of fields is a search the transfer mechanism is built for.

STRAT-01 to STRAT-05

Five device concepts, each designed for one disease: brain, lymphatic, breast, pancreatic and lung. In each, the applied field is a design object: a sequence of directions chosen to cover the sphere of division axes, electrode placement driven by the tissue the field must cross, and a tuned waveform rather than one fixed frequency.

Evidence: research-stage concepts developed computationally. Nothing has been tested in people and nothing here is a treatment claim. Next checkpoint: field simulation on anatomical tissue models.